EP17.27: Prognostic value of maternal N‐terminal pro‐B‐type natriuretic peptide for prediction of adverse maternal outcomes in women with pre‐eclampsia

Documenti analoghi

• EP04.05: Impact of the COVID‐19 pandemic on parvovirus B19 infection rates in pregnancy: is there a post‐pandemic epidemic?
  di: C. Haberl, et al.
  Pubblicazione: (2024)
• Development and validation of prediction model for pre‐eclampsia‐related maternal adverse outcome: retrospective cohort study
  di: M. Huang, et al.
  Pubblicazione: (2025)
• OP13.05: Assessment of the angiogenic ratio versus glycosylated fibronectin in predicting adverse maternal outcome in women with suspected pre‐eclampsia
  di: Y. Wah, et al.
  Pubblicazione: (2024)
• Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study
  di: X. Wang, et al.
  Pubblicazione: (2025)
• EP12.08: Risk of superimposed pre‐eclampsia and adverse outcomes in pregnant women with chronic hypertension
  di: M.V. Zaccaro, et al.
  Pubblicazione: (2024)